Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Radiation Oncology (London, England)|July 24, 2020
Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapyFrancesco Cuccia, Rosario Mazzola, Luca Nicosia, et al.
Radiation Oncology (London, England)|October 10, 2021
Reduction of inter-observer differences in the delineation of the target in spinal metastases SBRT using an automatic contouring dedicated systemNiccolò Giaj-Levra, Vanessa Figlia, Francesco Cuccia, et al.
Critical Reviews in Oncology/Hematology|March 18, 2019
Modern radiotherapy in cancer treatment during pregnancyRosario Mazzola, Stefanie Corradini, Markus Eidemüeller, et al.
Frontiers in Oncology|May 2, 2022
1.5T MR-Guided Daily Adaptive Stereotactic Body Radiotherapy for Prostate Re-Irradiation: A Preliminary Report of Toxicity and Clinical OutcomesFrancesco Cuccia, Michele Rigo, Vanessa Figlia, et al.
Journal of Clinical Medicine|June 19, 2024
SBRT in Lymph-Nodal Oligometastases from Prostate Cancer: Different Outcomes between Pelvic and Para-Aortic DiseaseEdoardo Pastorello, Luca Nicosia, Luca Triggiani, et al.
Technology in Cancer Research & Treatment|January 27, 2025
MR-Guided Adaptive Radiotherapy in Localized Prostate CancerAndrea Gaetano Allegra, Luca Nicosia, Michele Rigo, et al.
Journal of Cancer Research and Clinical Oncology|July 16, 2021
Mitigation on bowel loops daily variations by 1.5-T MR-guided daily-adaptive SBRT for abdomino-pelvic lymph-nodal oligometastasesFrancesco Cuccia, Michele Rigo, Davide Gurrera, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 31, 2024
Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi)Stefano Durante, Francesco Cuccia, Michele Rigo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi)Stefano Durante, Francesco Cuccia, Michele Rigo, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|October 22, 2020
Adaptive SBRT by 1.5 T MR-linac for prostate cancer: On the accuracy of dose delivery in view of the prolonged session timeRuggero Ruggieri, Michele Rigo, Stefania Naccarato, et al.
Pageof 5